Clinical characteristics | Group case (n = 529) | Group control (n = 529) | P value |
---|---|---|---|
Age range, years | 16–80 | 16–75 | - |
Mean age ± SD, years | 39.09 ± 10.57 | 38.60 ± 10.97 | 0.458a |
Gender n (%) | All male | All male | - |
Clinical stages, n (%) | Â | Â | Â |
I | 179 (33.84%) | - | - |
II | 144 (27.22%) | - | - |
III | 144 (27.22%) | - | - |
IV | 62 (11.72%) | - | - |
CD4+T cell counts (cell/mm3), n (%) | Â | Â | |
< 200 | 104 (19.66%) | - | - |
200–349 | 124 (23.44%) | - | - |
350–500 | 156 (29.49%) | - | - |
> 500 | 145 (27.41%) | - | - |